Stock Events

Stock Events

Viridian Therapeutics (VRDN) Q4 2024 Earnings

12NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-1.35

-1.16

-0.98

-0.79

Details

Expected EPS

-1.05725

Actual EPS

-1.15

Surprise EPS

-0.09

Surprise Percent

+8.77%

Description

Viridian Therapeutics (VRDN) has reported earnings of -1.15 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.